MX2008006711A - Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators. - Google Patents

Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators.

Info

Publication number
MX2008006711A
MX2008006711A MX2008006711A MX2008006711A MX2008006711A MX 2008006711 A MX2008006711 A MX 2008006711A MX 2008006711 A MX2008006711 A MX 2008006711A MX 2008006711 A MX2008006711 A MX 2008006711A MX 2008006711 A MX2008006711 A MX 2008006711A
Authority
MX
Mexico
Prior art keywords
compounds
identifying
methods
optimizing
synthesizing
Prior art date
Application number
MX2008006711A
Other languages
Spanish (es)
Inventor
Gerard M Housey
Original Assignee
Gerard M Housey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/633,890 external-priority patent/US20070129179A1/en
Application filed by Gerard M Housey filed Critical Gerard M Housey
Priority claimed from PCT/US2006/045394 external-priority patent/WO2007062213A2/en
Publication of MX2008006711A publication Critical patent/MX2008006711A/en

Links

Abstract

This invention relates to methods of identifying, synthesizing, optimizing and profiling compounds that are inhibitors or activators of proteins, both naturally occurring endogenous proteins as well as certain variant forms of endogenous proteins, and novel methods of identifying such variants. The method accelerates the identification and development of compounds as potential therapeutically effective drugs by simplifying the pharmaceutical discovery and creation process through improvements in hit identification, lead optimization, biological profiling, and rapid elimination of toxic compounds. Implementation results in overall cost, reductions in the drug discovery process resulting from the corresponding increases in efficiency.
MX2008006711A 2005-11-23 2006-11-24 Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators. MX2008006711A (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US73947605P 2005-11-23 2005-11-23
US73947705P 2005-11-23 2005-11-23
US74176705P 2005-12-02 2005-12-02
US75103005P 2005-12-16 2005-12-16
US78310606P 2006-03-13 2006-03-13
US78581706P 2006-03-23 2006-03-23
US78590406P 2006-03-23 2006-03-23
US78937906P 2006-04-04 2006-04-04
US11/633,890 US20070129179A1 (en) 2005-12-05 2006-08-29 Handheld electronic caddy scorekeeping device for a golfer
PCT/US2006/045394 WO2007062213A2 (en) 2005-11-23 2006-11-24 Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators

Publications (1)

Publication Number Publication Date
MX2008006711A true MX2008006711A (en) 2008-10-20

Family

ID=40941304

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008006711A MX2008006711A (en) 2005-11-23 2006-11-24 Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators.

Country Status (1)

Country Link
MX (1) MX2008006711A (en)

Similar Documents

Publication Publication Date Title
NO2017019I2 (en) Enzalutamide or a pharmaceutically acceptable salt thereof
EA200702048A1 (en) PHARMACOKINETICALLY IMPROVED COMPOUNDS
Mandemaker et al. DNA damage‐induced replication stress results in PA 200‐proteasome‐mediated degradation of acetylated histones
MY151036A (en) Synthesis of (r)-n-methylnaltrexone
EA200801571A1 (en) COMPOSITIONS CONTAINING CTL4-IG MOLECULES AND METHODS FOR THEIR RECEPTION
DE602004025101D1 (en) HUMAN ANTI-HUMANE CD3 BONDING MOLECULES
CY1111896T1 (en) NON-ADMINISTRATIVE PHARMACEUTICAL FORMS OF ORAL INCLUSIVE INCLUSIVE ANALYSIS
NO20082559L (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
NO20064893L (en) Synthesis of Boronic Acid Esters and Acid Compounds
EA200800909A1 (en) OBTAINING PREGABALIN AND RELATED COMPOUNDS
TW200716646A (en) (S)-N-methylnaltrexone
MX2007006640A (en) Biomarkers for pre-selection of patients for anti-igf1r therapy.
EA200870021A1 (en) HUMAN MONOCLONAL ANTIBODIES TO FUKOZIL-GM1 AND METHODS OF APPLICATION OF ANTI-FUKOSIL-GM1 ANTIBODIES
MX2012004258A (en) Inhibitors of bruton's tyrosine kinase.
EA201070247A1 (en) PROTEAS INHIBITORS
NO20053112L (en) Peptides that target tumor and endothelial cells, compositions and uses thereof.
MA27880A1 (en) TETRAHYDROCARBAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
WO2003076592A3 (en) Novel method for delivery and intracellular synthesis of sirna molecules
EA200701979A1 (en) METHOD FOR OBTAINING OPIOID MODULATORS
EA200702193A1 (en) GLYCOSILIZATION BELKOV
EA201390156A1 (en) PRODUCTION OF INTER-ALPHA INHIBITOR PROTEINS (IaIp) FROM PLASMA
IL176479A0 (en) Methods and compositions for identifying rna-binding proteins
TW200716132A (en) Novel chemical compounds
NO20060535L (en) Aztreonam-L-lysine and methods for preparing it

Legal Events

Date Code Title Description
FG Grant or registration